Skip to main content

Table 2 Changes of redox parameters by hemodialysis and comparisons between CHD and EHD phases

From: Amelioration of hemodialysis-induced oxidative stress and fatigue with a hemodialysis system employing electrolyzed water containing molecular hydrogen

  

CHD phase

E-HD phase

p (CHD vs. E-HD)

MPO (pg/mL)

pre-HD

427 ± 197

399 ± 205

0.413

post-

656 ± 289

834 ± 432

< 0.001

p (pre vs. post)

< 0.001

< 0.001

 

TRX (ng/mL)

pre-HD

107.3 ± 36.5

114.0 ± 44.2

0.065

post-

60.0 ± 34.6

76.2 ± 29.9

< 0.001

p (pre vs. post)

< 0.001

< 0.001

 

MDA-a (pmol/mL)

pre-HD

59.0 ± 21.4

61.7 ± 17.9

0.030

post-

72.9 ± 21.2

67.2 ± 18.3

< 0.001

p (pre vs. post)

< 0.001

0.004

 
  1. CHD Control HD; EHD HD employing electrolyzed water containing molecular hydrogen; MPO myeloperoxidase; RTX thioredoxin-1; MDA-a malondialdehyde-protein adduct
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us